Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × pomalidomide × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 79 Recurrence 17 Neoplasms 7 Neoplasms, Plasma Cell 3 Lymphoma, Non-Hodgkin 3 Sarcoma, Kaposi 2 Leukemia, Myeloid, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Acquired Immunodeficiency Syndrome 2 Waldenstrom Macroglobulinemia 1 Smoldering Multiple Myeloma 1 Proteostasis Deficiencies 1 Plasmacytoma 1 Plasmablastic Lymphoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1 Alzheimer Disease 1

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡